Literature DB >> 8530311

[Therapy of Frey syndrome with botulinum toxin A. Experiences with a new method of treatment].

C Drobik1, R Laskawi, S Schwab.   

Abstract

The effectiveness of botulinum toxin for the treatment of Frey's syndrome is demonstrated. Since December 1993, 14 patients with severe symptomatic gustatory sweating have been treated at the ENT Department, University of Göttingen. Botulinum toxin A (approximately 0.5 U/cm2) was injected intracutaneously into the affected skin area as determined by Minor's starch iodine test. Gustatory sweating in the treated skin area ceased completely within 2 days and did not reappear during the period of following (13 months maximum follow-up). There were no side effects. Findings show that local botulinum toxin injections are a highly effective, safe and minimally invasive treatment for Frey's syndrome. Moreover, this could be a new therapeutic tool for other forms of hyperhidrosis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8530311

Source DB:  PubMed          Journal:  HNO        ISSN: 0017-6192            Impact factor:   1.284


  5 in total

1.  [The incidence of Frey syndrome following parotidectomy: results of a survey and follow-up].

Authors:  A Neumann; D Rosenberger; O Vorsprach; S Dazert
Journal:  HNO       Date:  2011-02       Impact factor: 1.284

2.  [On the diagnosis and treatment of parotid gland tumors. Results of a nationwide survey of ENT hospitals in Germany].

Authors:  S F Preuss; O Guntinas-Lichius
Journal:  HNO       Date:  2006-11       Impact factor: 1.284

3.  Frey's syndrome--unusually long delayed clinical onset post-parotidectomy: a case report.

Authors:  Inchien Chamisa
Journal:  Pan Afr Med J       Date:  2010-04-07

4.  [Frey's syndrome of the external auditory canal].

Authors:  J Constantinidis; G Kyriafinis; S Ereliadis; J Daniilidis
Journal:  HNO       Date:  2004-10       Impact factor: 1.284

5.  Efficacy and safety of botulinum toxin type A for treatment of Frey's syndrome: evidence from 22 published articles.

Authors:  Shang Xie; Kan Wang; Tao Xu; Xue-Sheng Guo; Xiao-Feng Shan; Zhi-Gang Cai
Journal:  Cancer Med       Date:  2015-08-26       Impact factor: 4.452

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.